Last I heard, 23andme was using microarrays. The transition to massively parallel sequencing didn’t go well and they rolled back.

The DNA placed on the chip will be a heterogeneous mixture of whatever kind of cells provided. How they’d handle mosaicism, whether somatic or otherwise, I don’t know.